SPONSORED BY: Princess Margaret Hospital and the Department of Medicine, University of Toronto
Program Information
This year’s program will provide evidence-based updates on the management of multiple myeloma and amyloidosis, with emphasis on the Princess Margaret Hospital (PMH) approach. The program will be presented by specialists from PMH with Keynote Speaker – Dr. Ola Landgren. Lectures and interactive workshops will be featured and continental breakfast, refreshments and lunch included.
Keynote Lecture
"From Myeloma Precursor Disease to Multiple Myeloma"
Ola Landgren, MD, PhD
Medical Oncology Branch and Affiliates
Head, Multiple Myeloma Section
Senior Investigator
National Cancer Institute
Bethesda, Maryland, USA
Course Objectives
- To provide evidence-based updates on the management of multiple myeloma and amyloidosis
- To discuss the current management policies of the PMH myeloma group
- To review supportive care interventions in the myeloma patient
Target Audience
Community health practitioners including physicians, nurses, pharmacists, trainees, and other health care providers who are involved in the care of patients with plasma cell disorders will find this program of benefit.
Faculty and Speakers
Christine Chen, MD , Course Director
Ellen Church, RN
Sue Coffey, RN
Vishal Kukreti, MD
Donna Reece, MD
Diane Taylor, RN
Rodger Tiedemann, MD
Suzanne Trudel, MD
Victor Zepeda, MD